1 min read|29 words
π KEY STAT: GLP-1 medications reduce major cardiovascular events by 20% compared to placebo. The benefits go far beyond weight loss and diabetes control.
Read the full article on GMJ Newsroom β
Was this article helpful?
Key Finding: GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, AccrΓ©ditation Sans FrontiΓ¨res (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016β2021). ORCID: 0000-0001-7609-4515.
